

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.05308827 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.95925793 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 5.60884829 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 5.60884829 |
| 5 | tryptophan catabolic process (GO:0006569) | 5.60884829 |
| 6 | kynurenine metabolic process (GO:0070189) | 5.56694866 |
| 7 | behavioral response to nicotine (GO:0035095) | 5.47097936 |
| 8 | synaptic transmission, glutamatergic (GO:0035249) | 5.33412122 |
| 9 | protein localization to synapse (GO:0035418) | 5.19241684 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.16912438 |
| 11 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 5.16386716 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 5.14323927 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.12631712 |
| 14 | axonal fasciculation (GO:0007413) | 5.02329664 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.95482758 |
| 16 | nerve growth factor signaling pathway (GO:0038180) | 4.83126311 |
| 17 | protein polyglutamylation (GO:0018095) | 4.79570272 |
| 18 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.75825530 |
| 19 | glutamate secretion (GO:0014047) | 4.74127878 |
| 20 | muscle cell fate commitment (GO:0042693) | 4.72222870 |
| 21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.70459373 |
| 22 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.69537466 |
| 23 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.57221267 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.57170797 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.50384811 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.41881228 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.41586824 |
| 28 | neuronal action potential propagation (GO:0019227) | 4.41327672 |
| 29 | neuron recognition (GO:0008038) | 4.37790780 |
| 30 | DNA deamination (GO:0045006) | 4.34950456 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.31666568 |
| 32 | regulation of axon guidance (GO:1902667) | 4.28675905 |
| 33 | indolalkylamine metabolic process (GO:0006586) | 4.24744274 |
| 34 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.24292776 |
| 35 | regulation of vesicle fusion (GO:0031338) | 4.19067771 |
| 36 | postsynaptic membrane organization (GO:0001941) | 4.17373536 |
| 37 | positive regulation of vesicle fusion (GO:0031340) | 4.06882580 |
| 38 | fucose catabolic process (GO:0019317) | 4.06723922 |
| 39 | L-fucose metabolic process (GO:0042354) | 4.06723922 |
| 40 | L-fucose catabolic process (GO:0042355) | 4.06723922 |
| 41 | locomotory exploration behavior (GO:0035641) | 4.05773601 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 4.03762671 |
| 43 | head development (GO:0060322) | 4.03097274 |
| 44 | synaptic vesicle maturation (GO:0016188) | 4.02849517 |
| 45 | amine catabolic process (GO:0009310) | 4.02142602 |
| 46 | cellular biogenic amine catabolic process (GO:0042402) | 4.02142602 |
| 47 | urinary tract smooth muscle contraction (GO:0014848) | 3.98614575 |
| 48 | response to histamine (GO:0034776) | 3.97779569 |
| 49 | synaptic vesicle exocytosis (GO:0016079) | 3.97496885 |
| 50 | neuron cell-cell adhesion (GO:0007158) | 3.96887435 |
| 51 | axoneme assembly (GO:0035082) | 3.94454496 |
| 52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.91486695 |
| 53 | regulation of chromatin binding (GO:0035561) | 3.90658805 |
| 54 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.90391504 |
| 55 | parturition (GO:0007567) | 3.89439695 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.85891935 |
| 57 | presynaptic membrane assembly (GO:0097105) | 3.83416794 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.81498944 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.78774024 |
| 60 | positive regulation of dendritic spine development (GO:0060999) | 3.77971426 |
| 61 | cellular response to ATP (GO:0071318) | 3.76985493 |
| 62 | nonmotile primary cilium assembly (GO:0035058) | 3.76707843 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.73986877 |
| 64 | exploration behavior (GO:0035640) | 3.72252758 |
| 65 | regulation of cilium movement (GO:0003352) | 3.71903244 |
| 66 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.69565136 |
| 67 | axon extension involved in axon guidance (GO:0048846) | 3.69565136 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.68672472 |
| 69 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.68543951 |
| 70 | gonadal mesoderm development (GO:0007506) | 3.67521532 |
| 71 | long-term memory (GO:0007616) | 3.67123739 |
| 72 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.65313095 |
| 73 | behavioral defense response (GO:0002209) | 3.64322404 |
| 74 | behavioral fear response (GO:0001662) | 3.64322404 |
| 75 | cell proliferation in forebrain (GO:0021846) | 3.63227110 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 3.62955977 |
| 77 | mitotic cell cycle arrest (GO:0071850) | 3.61973553 |
| 78 | serotonin metabolic process (GO:0042428) | 3.61686090 |
| 79 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.59667727 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 3.57545600 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.57506666 |
| 82 | skeletal muscle fiber development (GO:0048741) | 3.55493549 |
| 83 | cell communication by electrical coupling (GO:0010644) | 3.53381629 |
| 84 | response to gravity (GO:0009629) | 3.52638300 |
| 85 | central nervous system neuron axonogenesis (GO:0021955) | 3.52631300 |
| 86 | regulation of respiratory system process (GO:0044065) | 3.50505422 |
| 87 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50226398 |
| 88 | regulation of glomerulus development (GO:0090192) | 3.47024064 |
| 89 | presynaptic membrane organization (GO:0097090) | 3.43291447 |
| 90 | membrane depolarization (GO:0051899) | 3.42169615 |
| 91 | positive regulation of catecholamine secretion (GO:0033605) | 3.38461187 |
| 92 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.36918685 |
| 93 | glomerular visceral epithelial cell development (GO:0072015) | 3.34000723 |
| 94 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33553319 |
| 95 | positive regulation of fibroblast migration (GO:0010763) | 3.32463774 |
| 96 | primary amino compound metabolic process (GO:1901160) | 3.31327018 |
| 97 | membrane depolarization during action potential (GO:0086010) | 3.29970284 |
| 98 | cellular response to estradiol stimulus (GO:0071392) | 3.25618280 |
| 99 | regulation of memory T cell differentiation (GO:0043380) | 3.25571507 |
| 100 | cytochrome complex assembly (GO:0017004) | 3.24628562 |
| 101 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24385848 |
| 102 | somite development (GO:0061053) | 3.22752145 |
| 103 | myotube cell development (GO:0014904) | 3.22505349 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.22198761 |
| 105 | regulation of synaptic plasticity (GO:0048167) | 3.21673680 |
| 106 | positive regulation of defense response to virus by host (GO:0002230) | 3.21505476 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.18205349 |
| 108 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.17628945 |
| 109 | kidney morphogenesis (GO:0060993) | 3.16077444 |
| 110 | fear response (GO:0042596) | 3.15387594 |
| 111 | regulation of synapse assembly (GO:0051963) | 3.14205290 |
| 112 | synaptic vesicle endocytosis (GO:0048488) | 3.11923983 |
| 113 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.10210078 |
| 114 | positive regulation of glomerulus development (GO:0090193) | 3.09976573 |
| 115 | aromatic amino acid family catabolic process (GO:0009074) | 3.08446694 |
| 116 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05621418 |
| 117 | gamma-aminobutyric acid transport (GO:0015812) | 3.05567708 |
| 118 | vocalization behavior (GO:0071625) | 3.04848788 |
| 119 | myotube differentiation (GO:0014902) | 3.03801109 |
| 120 | axonemal dynein complex assembly (GO:0070286) | 3.03602909 |
| 121 | positive regulation of membrane potential (GO:0045838) | 3.02219291 |
| 122 | negative regulation of cell cycle arrest (GO:0071157) | 3.01890386 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 2.99862309 |
| 124 | transmission of nerve impulse (GO:0019226) | 2.99584261 |
| 125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.99545197 |
| 126 | long-term synaptic potentiation (GO:0060291) | 2.99508336 |
| 127 | positive regulation of mitochondrial fission (GO:0090141) | 2.99269256 |
| 128 | positive regulation of synapse maturation (GO:0090129) | 2.99261775 |
| 129 | ovulation cycle (GO:0042698) | 2.99028361 |
| 130 | synaptic transmission, cholinergic (GO:0007271) | 2.98592507 |
| 131 | negative regulation of appetite (GO:0032099) | 2.97478784 |
| 132 | negative regulation of response to food (GO:0032096) | 2.97478784 |
| 133 | auditory receptor cell stereocilium organization (GO:0060088) | 2.97065234 |
| 134 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.96870905 |
| 135 | regulation of respiratory gaseous exchange (GO:0043576) | 2.96765523 |
| 136 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.96285192 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.95282605 |
| 138 | regulation of beta-amyloid formation (GO:1902003) | 2.94243766 |
| 139 | positive regulation of synapse assembly (GO:0051965) | 2.94136742 |
| 140 | benzene-containing compound metabolic process (GO:0042537) | 2.93795510 |
| 141 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.93396370 |
| 142 | response to pheromone (GO:0019236) | 2.93275148 |
| 143 | sulfate transmembrane transport (GO:1902358) | 2.93089649 |
| 144 | dendritic spine morphogenesis (GO:0060997) | 2.92563367 |
| 145 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90934990 |
| 146 | glomerular epithelial cell development (GO:0072310) | 2.90863404 |
| 147 | epithelial cilium movement (GO:0003351) | 2.90466182 |
| 148 | regulation of microtubule-based movement (GO:0060632) | 2.89849331 |
| 149 | neuromuscular process controlling posture (GO:0050884) | 2.89528988 |
| 150 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.88888070 |
| 151 | response to nerve growth factor (GO:1990089) | 2.88888070 |
| 152 | neuromuscular synaptic transmission (GO:0007274) | 2.88516498 |
| 153 | hypothalamus development (GO:0021854) | 2.86545270 |
| 154 | suckling behavior (GO:0001967) | 2.86271704 |
| 155 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.85221388 |
| 156 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.85021383 |
| 157 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.84387065 |
| 158 | adaptation of signaling pathway (GO:0023058) | 2.83127649 |
| 159 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.83117216 |
| 160 | calcium ion import (GO:0070509) | 2.81796884 |
| 161 | neurotransmitter secretion (GO:0007269) | 2.80059363 |
| 162 | detection of temperature stimulus (GO:0016048) | 2.79342507 |
| 163 | regulation of synapse organization (GO:0050807) | 2.79316202 |
| 164 | cellular response to exogenous dsRNA (GO:0071360) | 2.75309220 |
| 165 | spinal cord association neuron differentiation (GO:0021527) | 2.74011513 |
| 166 | detection of light stimulus involved in visual perception (GO:0050908) | 2.73172397 |
| 167 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.73172397 |
| 168 | positive regulation of fatty acid oxidation (GO:0046321) | 2.73054502 |
| 169 | regulation of mitochondrial fission (GO:0090140) | 2.71835707 |
| 170 | lens fiber cell differentiation (GO:0070306) | 2.68532881 |
| 171 | sulfation (GO:0051923) | 2.68441172 |
| 172 | negative regulation of heart rate (GO:0010459) | 2.67981228 |
| 173 | cytidine metabolic process (GO:0046087) | 2.64874735 |
| 174 | cytidine catabolic process (GO:0006216) | 2.64874735 |
| 175 | cytidine deamination (GO:0009972) | 2.64874735 |
| 176 | cilium movement (GO:0003341) | 2.64840404 |
| 177 | negative regulation of telomere maintenance (GO:0032205) | 2.64301484 |
| 178 | brain morphogenesis (GO:0048854) | 2.63909227 |
| 179 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.63041869 |
| 180 | oxidative demethylation (GO:0070989) | 2.61757259 |
| 181 | ketone body metabolic process (GO:1902224) | 2.56026811 |
| 182 | sulfate transport (GO:0008272) | 2.55761378 |
| 183 | dentate gyrus development (GO:0021542) | 2.54506700 |
| 184 | response to testosterone (GO:0033574) | 2.53190759 |
| 185 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.53171259 |
| 186 | cornea development in camera-type eye (GO:0061303) | 2.51907804 |
| 187 | positive regulation by host of viral transcription (GO:0043923) | 2.51372889 |
| 188 | protein complex biogenesis (GO:0070271) | 2.51206281 |
| 189 | nephron tubule formation (GO:0072079) | 2.49259934 |
| 190 | striated muscle atrophy (GO:0014891) | 2.48148347 |
| 191 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.47953855 |
| 192 | regulation of neurotransmitter uptake (GO:0051580) | 2.47343347 |
| 193 | motile cilium assembly (GO:0044458) | 2.46843314 |
| 194 | cellular anion homeostasis (GO:0030002) | 2.46059097 |
| 195 | regulation of gene silencing by RNA (GO:0060966) | 2.44015737 |
| 196 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.44015737 |
| 197 | regulation of gene silencing by miRNA (GO:0060964) | 2.44015737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.42449812 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 5.03555860 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.62266457 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71753852 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66596779 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.60236518 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58837159 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37412825 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35240017 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21681774 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20641682 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15677709 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15170958 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14951617 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12448838 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12448838 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07172957 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06933287 |
| 19 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.04708725 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02533928 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99271349 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98591604 |
| 23 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.98051898 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.94324243 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92872341 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89530000 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88941433 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87772629 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85364340 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80424769 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80277449 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79794550 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79397176 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76541028 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74185588 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68075648 |
| 37 | ERA_21632823_ChIP-Seq_H3396_Human | 1.67897969 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66643972 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64224843 |
| 40 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.63915022 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63595220 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60303516 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.57396194 |
| 44 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.55514226 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54399390 |
| 46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52289276 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50668944 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49996167 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48809642 |
| 50 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.46807186 |
| 51 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.46327770 |
| 52 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43635590 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43402759 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42575098 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.36288742 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35501359 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34575726 |
| 58 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.34527942 |
| 59 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.34270076 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33788381 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31892013 |
| 62 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30150578 |
| 63 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.29651084 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27914730 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27797531 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26604505 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26254851 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25952655 |
| 69 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24947790 |
| 70 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.23211276 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23056221 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22941479 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21397836 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21188434 |
| 75 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20992226 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20660903 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20561051 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20301530 |
| 79 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.19575295 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17594375 |
| 81 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.14345977 |
| 82 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.14088946 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13200169 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.13193082 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13153709 |
| 86 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.12982938 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12673525 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12132658 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12111940 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09473965 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08286735 |
| 92 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08166259 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08159463 |
| 94 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07614483 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06748490 |
| 96 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06521338 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06008754 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05612204 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04190438 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03709900 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03662913 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03351214 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03008976 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02275138 |
| 105 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02260029 |
| 106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00377766 |
| 107 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00197049 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00121024 |
| 109 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00078602 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98701798 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98397050 |
| 112 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.98118644 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97753394 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97174226 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97119007 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96971697 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96622248 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96285319 |
| 119 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.96244057 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96118228 |
| 121 | P300_27268052_Chip-Seq_Bcells_Human | 0.96040555 |
| 122 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95961965 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95811704 |
| 124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95311167 |
| 125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95239945 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95142912 |
| 127 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94853132 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94566622 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94086247 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93922318 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93849064 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93144552 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92760026 |
| 134 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92729075 |
| 135 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92607008 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91419931 |
| 137 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91170521 |
| 138 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91170521 |
| 139 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91106109 |
| 140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90733927 |
| 141 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88934467 |
| 142 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88934467 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88788472 |
| 144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88640733 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88591690 |
| 146 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88521640 |
| 147 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88064253 |
| 148 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88063230 |
| 149 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88007134 |
| 150 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.87590739 |
| 151 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87433797 |
| 152 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.86697978 |
| 153 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86513671 |
| 154 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85817955 |
| 155 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84464948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.66823097 |
| 2 | MP0003880_abnormal_central_pattern | 6.63224847 |
| 3 | MP0002735_abnormal_chemical_nociception | 4.44699025 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.70728541 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.68333171 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.60123917 |
| 7 | MP0002736_abnormal_nociception_after | 3.30282866 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.22293454 |
| 9 | MP0009745_abnormal_behavioral_response | 3.01711723 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.90043649 |
| 11 | MP0003283_abnormal_digestive_organ | 2.88760577 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86338021 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.82333167 |
| 14 | MP0002064_seizures | 2.79066753 |
| 15 | MP0002822_catalepsy | 2.68845572 |
| 16 | MP0003011_delayed_dark_adaptation | 2.68712345 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.44409511 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.43091092 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.30708423 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.28202806 |
| 21 | MP0002272_abnormal_nervous_system | 2.28008300 |
| 22 | MP0004381_abnormal_hair_follicle | 2.25109024 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.12412868 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.09749111 |
| 25 | MP0002234_abnormal_pharynx_morphology | 2.06381328 |
| 26 | MP0004270_analgesia | 1.96811627 |
| 27 | MP0003879_abnormal_hair_cell | 1.95894682 |
| 28 | MP0003195_calcinosis | 1.86925212 |
| 29 | MP0003122_maternal_imprinting | 1.85859914 |
| 30 | MP0004142_abnormal_muscle_tone | 1.84380057 |
| 31 | MP0000631_abnormal_neuroendocrine_gland | 1.81782766 |
| 32 | MP0003646_muscle_fatigue | 1.81578841 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.75949621 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.74924316 |
| 35 | MP0009046_muscle_twitch | 1.70877709 |
| 36 | MP0004134_abnormal_chest_morphology | 1.70797506 |
| 37 | MP0001984_abnormal_olfaction | 1.69634134 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.67556105 |
| 39 | MP0000955_abnormal_spinal_cord | 1.65859371 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.63795527 |
| 41 | MP0003878_abnormal_ear_physiology | 1.63795527 |
| 42 | MP0008872_abnormal_physiological_respon | 1.61656912 |
| 43 | MP0004858_abnormal_nervous_system | 1.59200421 |
| 44 | MP0001970_abnormal_pain_threshold | 1.58484602 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.55055815 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.52900373 |
| 47 | MP0004133_heterotaxia | 1.51575105 |
| 48 | MP0002184_abnormal_innervation | 1.45527230 |
| 49 | MP0005670_abnormal_white_adipose | 1.44269039 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.41885414 |
| 51 | MP0001486_abnormal_startle_reflex | 1.40380973 |
| 52 | MP0001905_abnormal_dopamine_level | 1.38520132 |
| 53 | MP0000778_abnormal_nervous_system | 1.36794395 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.31497185 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 1.30592180 |
| 56 | MP0003787_abnormal_imprinting | 1.26421479 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.26321503 |
| 58 | MP0008569_lethality_at_weaning | 1.25793902 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.25683025 |
| 60 | MP0002163_abnormal_gland_morphology | 1.24973655 |
| 61 | MP0002254_reproductive_system_inflammat | 1.23479302 |
| 62 | MP0002249_abnormal_larynx_morphology | 1.23258565 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.23033973 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.22982087 |
| 65 | MP0002102_abnormal_ear_morphology | 1.22880926 |
| 66 | MP0001542_abnormal_bone_strength | 1.21745556 |
| 67 | MP0000026_abnormal_inner_ear | 1.21505860 |
| 68 | MP0003329_amyloid_beta_deposits | 1.19495898 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.17886251 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.16887661 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.15467826 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.14372192 |
| 73 | MP0004885_abnormal_endolymph | 1.11115099 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 1.10433110 |
| 75 | MP0005389_reproductive_system_phenotype | 1.07736535 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.05668865 |
| 77 | MP0005253_abnormal_eye_physiology | 1.03460180 |
| 78 | MP0008995_early_reproductive_senescence | 1.02329058 |
| 79 | MP0000749_muscle_degeneration | 1.01655762 |
| 80 | MP0002160_abnormal_reproductive_system | 1.01582701 |
| 81 | MP0003121_genomic_imprinting | 1.01130773 |
| 82 | MP0001986_abnormal_taste_sensitivity | 1.00813110 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.00603081 |
| 84 | MP0000733_abnormal_muscle_development | 1.00451275 |
| 85 | MP0005671_abnormal_response_to | 0.99885974 |
| 86 | MP0002928_abnormal_bile_duct | 0.99418669 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.98600969 |
| 88 | MP0001188_hyperpigmentation | 0.97443232 |
| 89 | MP0000681_abnormal_thyroid_gland | 0.97184679 |
| 90 | MP0002938_white_spotting | 0.97130788 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.96463115 |
| 92 | MP0004510_myositis | 0.95535197 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 0.95187749 |
| 94 | MP0005195_abnormal_posterior_eye | 0.94704366 |
| 95 | MP0000049_abnormal_middle_ear | 0.93039586 |
| 96 | MP0000427_abnormal_hair_cycle | 0.91969946 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.90830595 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.89567996 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.88956328 |
| 100 | MP0005499_abnormal_olfactory_system | 0.88956328 |
| 101 | MP0005360_urolithiasis | 0.88895788 |
| 102 | MP0003632_abnormal_nervous_system | 0.86318284 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.85478651 |
| 104 | MP0000467_abnormal_esophagus_morphology | 0.84735766 |
| 105 | MP0002751_abnormal_autonomic_nervous | 0.83132294 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.82273935 |
| 107 | MP0006054_spinal_hemorrhage | 0.81735570 |
| 108 | MP0001529_abnormal_vocalization | 0.81729054 |
| 109 | MP0005448_abnormal_energy_balance | 0.81702306 |
| 110 | MP0003075_altered_response_to | 0.81075928 |
| 111 | MP0001919_abnormal_reproductive_system | 0.80808678 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.79784475 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.78205264 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.77209296 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.74829659 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.74592505 |
| 117 | MP0003633_abnormal_nervous_system | 0.72766512 |
| 118 | MP0002152_abnormal_brain_morphology | 0.72186646 |
| 119 | MP0003631_nervous_system_phenotype | 0.71760170 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.71419784 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.71297531 |
| 122 | MP0002229_neurodegeneration | 0.70999573 |
| 123 | MP0005171_absent_coat_pigmentation | 0.70105891 |
| 124 | MP0002269_muscular_atrophy | 0.69378615 |
| 125 | MP0003690_abnormal_glial_cell | 0.68981687 |
| 126 | MP0000751_myopathy | 0.66421544 |
| 127 | MP0003938_abnormal_ear_development | 0.63689585 |
| 128 | MP0003045_fibrosis | 0.62936749 |
| 129 | MP0008874_decreased_physiological_sensi | 0.62819096 |
| 130 | MP0005551_abnormal_eye_electrophysiolog | 0.62639860 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.62198661 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.61024680 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.60874447 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.59894084 |
| 135 | MP0001177_atelectasis | 0.59871511 |
| 136 | MP0004215_abnormal_myocardial_fiber | 0.59729114 |
| 137 | MP0004742_abnormal_vestibular_system | 0.59240740 |
| 138 | MP0006276_abnormal_autonomic_nervous | 0.58627083 |
| 139 | MP0005310_abnormal_salivary_gland | 0.58300987 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.57571280 |
| 141 | MP0002090_abnormal_vision | 0.56697672 |
| 142 | MP0005367_renal/urinary_system_phenotyp | 0.56551475 |
| 143 | MP0000516_abnormal_urinary_system | 0.56551475 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.56406331 |
| 145 | MP0004924_abnormal_behavior | 0.56406331 |
| 146 | MP0000747_muscle_weakness | 0.55530436 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.52813085 |
| 148 | MP0004085_abnormal_heartbeat | 0.52231459 |
| 149 | MP0000759_abnormal_skeletal_muscle | 0.51439682 |
| 150 | MP0003698_abnormal_male_reproductive | 0.51384102 |
| 151 | MP0004043_abnormal_pH_regulation | 0.50269736 |
| 152 | MP0003123_paternal_imprinting | 0.48021778 |
| 153 | MP0002233_abnormal_nose_morphology | 0.47865411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.10060965 |
| 2 | Myokymia (HP:0002411) | 4.81838525 |
| 3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.58538578 |
| 4 | Focal seizures (HP:0007359) | 4.51321562 |
| 5 | Febrile seizures (HP:0002373) | 4.30986906 |
| 6 | Reduced antithrombin III activity (HP:0001976) | 4.13124545 |
| 7 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.07030504 |
| 8 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.00565169 |
| 9 | Aplasia of the phalanges of the hand (HP:0009802) | 4.00565169 |
| 10 | Aplasia involving bones of the extremities (HP:0009825) | 4.00565169 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.77503298 |
| 12 | Abnormality of midbrain morphology (HP:0002418) | 3.77503298 |
| 13 | Dysdiadochokinesis (HP:0002075) | 3.73923344 |
| 14 | Genetic anticipation (HP:0003743) | 3.70172000 |
| 15 | Pancreatic cysts (HP:0001737) | 3.67931257 |
| 16 | Atonic seizures (HP:0010819) | 3.63633400 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.59491088 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.55170367 |
| 19 | Dialeptic seizures (HP:0011146) | 3.53385489 |
| 20 | Absence seizures (HP:0002121) | 3.46078120 |
| 21 | Hypoplastic nipples (HP:0002557) | 3.32079962 |
| 22 | Exotropia (HP:0000577) | 3.31720092 |
| 23 | Cutaneous finger syndactyly (HP:0010554) | 3.20061468 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 3.19841096 |
| 25 | Protruding tongue (HP:0010808) | 3.13462145 |
| 26 | Oligodactyly (hands) (HP:0001180) | 3.10728017 |
| 27 | Nephronophthisis (HP:0000090) | 3.09639903 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 3.05158331 |
| 29 | True hermaphroditism (HP:0010459) | 3.04696349 |
| 30 | Broad-based gait (HP:0002136) | 3.01030388 |
| 31 | Obstructive sleep apnea (HP:0002870) | 3.00285284 |
| 32 | Methylmalonic acidemia (HP:0002912) | 2.99817749 |
| 33 | Abnormality of macular pigmentation (HP:0008002) | 2.98755764 |
| 34 | Anterior segment dysgenesis (HP:0007700) | 2.95228616 |
| 35 | Type 2 muscle fiber atrophy (HP:0003554) | 2.94613449 |
| 36 | Agitation (HP:0000713) | 2.94306556 |
| 37 | Postural instability (HP:0002172) | 2.94305274 |
| 38 | Hemiparesis (HP:0001269) | 2.93135806 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.91678533 |
| 40 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.91678533 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88590349 |
| 42 | Nonprogressive disorder (HP:0003680) | 2.88005029 |
| 43 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.87325488 |
| 44 | Abnormality of the renal medulla (HP:0100957) | 2.82526399 |
| 45 | Lower limb amyotrophy (HP:0007210) | 2.81007117 |
| 46 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.79133897 |
| 47 | Calf muscle hypertrophy (HP:0008981) | 2.75854315 |
| 48 | Generalized tonic-clonic seizures (HP:0002069) | 2.71610809 |
| 49 | Cystic liver disease (HP:0006706) | 2.70989802 |
| 50 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.70032934 |
| 51 | Bundle branch block (HP:0011710) | 2.70023597 |
| 52 | Gonadotropin excess (HP:0000837) | 2.68345928 |
| 53 | Ulnar claw (HP:0001178) | 2.65912636 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.56179329 |
| 55 | Lower limb asymmetry (HP:0100559) | 2.56160266 |
| 56 | Annular pancreas (HP:0001734) | 2.55927612 |
| 57 | Muscle fiber atrophy (HP:0100295) | 2.55701192 |
| 58 | Dysmetria (HP:0001310) | 2.54720652 |
| 59 | Cutaneous syndactyly (HP:0012725) | 2.54337502 |
| 60 | Hypoventilation (HP:0002791) | 2.53438471 |
| 61 | Hypoproteinemia (HP:0003075) | 2.51462485 |
| 62 | Abnormal number of erythroid precursors (HP:0012131) | 2.48992599 |
| 63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.45926775 |
| 64 | Abnormality of DNA repair (HP:0003254) | 2.44815003 |
| 65 | Abnormal ciliary motility (HP:0012262) | 2.43681455 |
| 66 | Pendular nystagmus (HP:0012043) | 2.43300411 |
| 67 | Truncal ataxia (HP:0002078) | 2.42959793 |
| 68 | Confusion (HP:0001289) | 2.42420471 |
| 69 | Supernumerary nipples (HP:0002558) | 2.42179552 |
| 70 | Asplenia (HP:0001746) | 2.41133846 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.39318264 |
| 72 | Ventricular arrhythmia (HP:0004308) | 2.38969606 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.35371999 |
| 74 | Absent/shortened dynein arms (HP:0200106) | 2.35371999 |
| 75 | Medial flaring of the eyebrow (HP:0010747) | 2.35360155 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.34710133 |
| 77 | Hyperactive renin-angiotensin system (HP:0000841) | 2.32917086 |
| 78 | Porencephaly (HP:0002132) | 2.32694437 |
| 79 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31193718 |
| 80 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.30745951 |
| 81 | Difficulty climbing stairs (HP:0003551) | 2.30295553 |
| 82 | Upper limb muscle weakness (HP:0003484) | 2.29587405 |
| 83 | Popliteal pterygium (HP:0009756) | 2.28136046 |
| 84 | Sclerocornea (HP:0000647) | 2.27893927 |
| 85 | Torticollis (HP:0000473) | 2.27869339 |
| 86 | Weak cry (HP:0001612) | 2.27611642 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 2.26258191 |
| 88 | Hyperalaninemia (HP:0003348) | 2.26258191 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26258191 |
| 90 | Abnormal pancreas size (HP:0012094) | 2.25440709 |
| 91 | Chorioretinal atrophy (HP:0000533) | 2.25376712 |
| 92 | Tubulointerstitial nephritis (HP:0001970) | 2.24732916 |
| 93 | Atrial fibrillation (HP:0005110) | 2.22860401 |
| 94 | Abnormality of dental color (HP:0011073) | 2.21412441 |
| 95 | Shoulder girdle muscle weakness (HP:0003547) | 2.19774075 |
| 96 | Hypoplasia of the uterus (HP:0000013) | 2.18618443 |
| 97 | Decreased central vision (HP:0007663) | 2.18103832 |
| 98 | Visual hallucinations (HP:0002367) | 2.17105149 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 2.16398300 |
| 100 | Primary atrial arrhythmia (HP:0001692) | 2.15577010 |
| 101 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.14714121 |
| 102 | Homocystinuria (HP:0002156) | 2.13645064 |
| 103 | Abnormality of homocysteine metabolism (HP:0010919) | 2.13645064 |
| 104 | Turricephaly (HP:0000262) | 2.13398539 |
| 105 | Syncope (HP:0001279) | 2.12577068 |
| 106 | Global brain atrophy (HP:0002283) | 2.11103956 |
| 107 | Abnormal EKG (HP:0003115) | 2.10575672 |
| 108 | Hypoplastic ischia (HP:0003175) | 2.10025573 |
| 109 | Abnormality of the renal collecting system (HP:0004742) | 2.09685587 |
| 110 | Horseshoe kidney (HP:0000085) | 2.08623307 |
| 111 | Thoracic kyphosis (HP:0002942) | 2.07311080 |
| 112 | Distal lower limb muscle weakness (HP:0009053) | 2.07075287 |
| 113 | Pointed chin (HP:0000307) | 2.06857552 |
| 114 | Subaortic stenosis (HP:0001682) | 2.06060267 |
| 115 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.06060267 |
| 116 | Adrenal hypoplasia (HP:0000835) | 2.05720471 |
| 117 | Disproportionate short-trunk short stature (HP:0003521) | 2.05494533 |
| 118 | Abnormality of the calf musculature (HP:0001430) | 2.04680662 |
| 119 | Pigmentary retinal degeneration (HP:0001146) | 2.03296177 |
| 120 | Fetal akinesia sequence (HP:0001989) | 2.01858630 |
| 121 | Hyperventilation (HP:0002883) | 2.01835668 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.00527921 |
| 123 | Abnormality of the renal cortex (HP:0011035) | 2.00488604 |
| 124 | Keratoconus (HP:0000563) | 2.00247178 |
| 125 | Increased corneal curvature (HP:0100692) | 2.00247178 |
| 126 | Pelvic girdle muscle weakness (HP:0003749) | 2.00052749 |
| 127 | Supraventricular tachycardia (HP:0004755) | 1.98509410 |
| 128 | Methylmalonic aciduria (HP:0012120) | 1.98422150 |
| 129 | Breast aplasia (HP:0100783) | 1.98347360 |
| 130 | Anosmia (HP:0000458) | 1.98317216 |
| 131 | Cerebellar dysplasia (HP:0007033) | 1.98272436 |
| 132 | Hemiplegia (HP:0002301) | 1.97948283 |
| 133 | Type I transferrin isoform profile (HP:0003642) | 1.96788876 |
| 134 | Hyperkalemia (HP:0002153) | 1.96423629 |
| 135 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95108174 |
| 136 | Congenital sensorineural hearing impairment (HP:0008527) | 1.94736311 |
| 137 | Anencephaly (HP:0002323) | 1.94357570 |
| 138 | Type II lissencephaly (HP:0007260) | 1.94021703 |
| 139 | Vaginal atresia (HP:0000148) | 1.92716467 |
| 140 | Fair hair (HP:0002286) | 1.92385855 |
| 141 | Clumsiness (HP:0002312) | 1.92151565 |
| 142 | Supraventricular arrhythmia (HP:0005115) | 1.91708169 |
| 143 | Increased IgE level (HP:0003212) | 1.91164870 |
| 144 | Hyperthyroidism (HP:0000836) | 1.90831237 |
| 145 | Concave nail (HP:0001598) | 1.90655631 |
| 146 | Fatigable weakness (HP:0003473) | 1.89610953 |
| 147 | Abnormality of the neuromuscular junction (HP:0003398) | 1.89610953 |
| 148 | Severe muscular hypotonia (HP:0006829) | 1.88782565 |
| 149 | Shawl scrotum (HP:0000049) | 1.88391665 |
| 150 | Short nail (HP:0001799) | 1.88388262 |
| 151 | Genital tract atresia (HP:0001827) | 1.86897068 |
| 152 | Poor eye contact (HP:0000817) | 1.86497030 |
| 153 | Bradycardia (HP:0001662) | 1.86170898 |
| 154 | Gait imbalance (HP:0002141) | 1.84679316 |
| 155 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.84542288 |
| 156 | Sleep apnea (HP:0010535) | 1.84532278 |
| 157 | Incomplete penetrance (HP:0003829) | 1.84389172 |
| 158 | Focal dystonia (HP:0004373) | 1.83835162 |
| 159 | Enlarged epiphyses (HP:0010580) | 1.82648491 |
| 160 | Insomnia (HP:0100785) | 1.82614569 |
| 161 | Generalized hypopigmentation of hair (HP:0011358) | 1.80880977 |
| 162 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79725338 |
| 163 | Increased circulating renin level (HP:0000848) | 1.78579195 |
| 164 | Congenital primary aphakia (HP:0007707) | 1.77030588 |
| 165 | Progressive cerebellar ataxia (HP:0002073) | 1.76981604 |
| 166 | Flat cornea (HP:0007720) | 1.76392564 |
| 167 | Sudden death (HP:0001699) | 1.76337994 |
| 168 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75631811 |
| 169 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.75342974 |
| 170 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.75342974 |
| 171 | Abnormality of the lower motor neuron (HP:0002366) | 1.74965125 |
| 172 | Ectopic kidney (HP:0000086) | 1.74620543 |
| 173 | Chronic bronchitis (HP:0004469) | 1.73987742 |
| 174 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73714210 |
| 175 | Duplicated collecting system (HP:0000081) | 1.73691331 |
| 176 | Lissencephaly (HP:0001339) | 1.73326209 |
| 177 | Stereotypic behavior (HP:0000733) | 1.72843717 |
| 178 | Double outlet right ventricle (HP:0001719) | 1.72391820 |
| 179 | Congenital malformation of the right heart (HP:0011723) | 1.72391820 |
| 180 | Absent thumb (HP:0009777) | 1.72128867 |
| 181 | Optic nerve coloboma (HP:0000588) | 1.69663024 |
| 182 | Short femoral neck (HP:0100864) | 1.69280508 |
| 183 | Renal dysplasia (HP:0000110) | 1.68887765 |
| 184 | Furrowed tongue (HP:0000221) | 1.67273987 |
| 185 | Oligohydramnios (HP:0001562) | 1.67057977 |
| 186 | Pachygyria (HP:0001302) | 1.67047566 |
| 187 | Anomalous pulmonary venous return (HP:0010772) | 1.65837981 |
| 188 | Synostosis of carpal bones (HP:0005048) | 1.65726344 |
| 189 | Hepatocellular necrosis (HP:0001404) | 1.64781084 |
| 190 | Decreased circulating renin level (HP:0003351) | 1.63268913 |
| 191 | Impaired smooth pursuit (HP:0007772) | 1.60608709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 8.73688244 |
| 2 | NTRK3 | 7.47668232 |
| 3 | EPHA4 | 5.32506337 |
| 4 | FRK | 3.94972039 |
| 5 | PRPF4B | 3.62547692 |
| 6 | TLK1 | 3.34684515 |
| 7 | ADRBK2 | 2.86804885 |
| 8 | EPHA3 | 2.53294666 |
| 9 | MAP3K9 | 2.52998346 |
| 10 | STK16 | 2.48819856 |
| 11 | MAPKAPK3 | 2.45709019 |
| 12 | MAP3K11 | 2.22959676 |
| 13 | BMPR1B | 2.16857961 |
| 14 | FGFR2 | 2.12585963 |
| 15 | NLK | 2.11547979 |
| 16 | TAOK2 | 2.09210082 |
| 17 | DDR2 | 2.02825053 |
| 18 | CAMKK2 | 1.92359373 |
| 19 | BRD4 | 1.89994363 |
| 20 | CSNK1A1L | 1.82403416 |
| 21 | TAOK3 | 1.78310660 |
| 22 | MAP4K2 | 1.77094300 |
| 23 | STK38L | 1.72607175 |
| 24 | GRK1 | 1.68606861 |
| 25 | WNK4 | 1.67238281 |
| 26 | CSNK1G3 | 1.66815626 |
| 27 | MAP4K1 | 1.65025855 |
| 28 | MAP3K14 | 1.64992244 |
| 29 | STK38 | 1.64132610 |
| 30 | NTRK1 | 1.61352952 |
| 31 | DAPK2 | 1.55079131 |
| 32 | TNK2 | 1.48689485 |
| 33 | MAP2K7 | 1.42697660 |
| 34 | TYRO3 | 1.41555390 |
| 35 | TAOK1 | 1.40786153 |
| 36 | WNK3 | 1.33241082 |
| 37 | CAMK1 | 1.27605237 |
| 38 | TXK | 1.25621333 |
| 39 | CSNK1G1 | 1.24446996 |
| 40 | SIK3 | 1.22588529 |
| 41 | INSRR | 1.18311978 |
| 42 | PRKCI | 1.09107524 |
| 43 | KSR2 | 1.04992742 |
| 44 | MAPK13 | 1.04453931 |
| 45 | CAMKK1 | 1.03340832 |
| 46 | EIF2AK3 | 1.03059675 |
| 47 | ITK | 1.02514665 |
| 48 | MAP3K13 | 1.01883732 |
| 49 | PASK | 1.00820607 |
| 50 | CAMK1D | 1.00157888 |
| 51 | KSR1 | 0.98654029 |
| 52 | SCYL2 | 0.98392705 |
| 53 | DAPK1 | 0.98234929 |
| 54 | MAP3K4 | 0.96712855 |
| 55 | PAK6 | 0.92455649 |
| 56 | CAMK2A | 0.90634676 |
| 57 | TRPM7 | 0.89449232 |
| 58 | AKT3 | 0.88745384 |
| 59 | MARK2 | 0.88196887 |
| 60 | MUSK | 0.87681563 |
| 61 | PRKD2 | 0.86856009 |
| 62 | FER | 0.84191359 |
| 63 | ARAF | 0.81786562 |
| 64 | FES | 0.80026969 |
| 65 | DYRK2 | 0.79243450 |
| 66 | CAMK4 | 0.78232484 |
| 67 | CDC42BPA | 0.75079488 |
| 68 | CAMK2B | 0.74169066 |
| 69 | SIK2 | 0.73637336 |
| 70 | PLK2 | 0.72645966 |
| 71 | EIF2AK1 | 0.72423512 |
| 72 | ERBB2 | 0.72152988 |
| 73 | CDK3 | 0.71803735 |
| 74 | MAP3K7 | 0.71650508 |
| 75 | PTK2B | 0.70539939 |
| 76 | MATK | 0.69510167 |
| 77 | MAP2K2 | 0.68707272 |
| 78 | MARK1 | 0.68514569 |
| 79 | NTRK2 | 0.67166468 |
| 80 | CDK8 | 0.67009115 |
| 81 | PDGFRA | 0.63410983 |
| 82 | MAPK15 | 0.62959763 |
| 83 | MAP3K1 | 0.61659659 |
| 84 | CASK | 0.60944425 |
| 85 | PRKCG | 0.60869182 |
| 86 | CDK5 | 0.60686670 |
| 87 | BLK | 0.56883491 |
| 88 | BCKDK | 0.56689543 |
| 89 | STK24 | 0.56285033 |
| 90 | ZAK | 0.56208101 |
| 91 | MST4 | 0.56133322 |
| 92 | TGFBR1 | 0.55381882 |
| 93 | CSNK1A1 | 0.53909550 |
| 94 | GRK7 | 0.50812841 |
| 95 | MINK1 | 0.48869734 |
| 96 | CAMK2D | 0.48129367 |
| 97 | HIPK2 | 0.47265884 |
| 98 | BRSK2 | 0.47160731 |
| 99 | ADRBK1 | 0.47081383 |
| 100 | EIF2AK2 | 0.46773939 |
| 101 | SGK1 | 0.45030818 |
| 102 | PINK1 | 0.44040928 |
| 103 | LIMK1 | 0.42199095 |
| 104 | PKN1 | 0.42189185 |
| 105 | NUAK1 | 0.40460117 |
| 106 | CSNK1D | 0.39851686 |
| 107 | CHUK | 0.38921564 |
| 108 | CDK15 | 0.38690605 |
| 109 | PRKCQ | 0.38202622 |
| 110 | CDK18 | 0.38027466 |
| 111 | STK11 | 0.37932497 |
| 112 | JAK1 | 0.37845148 |
| 113 | LATS1 | 0.37440407 |
| 114 | GRK5 | 0.36153488 |
| 115 | LCK | 0.35306600 |
| 116 | CDK7 | 0.34884549 |
| 117 | PHKG1 | 0.34832363 |
| 118 | PHKG2 | 0.34832363 |
| 119 | PRKD1 | 0.34763073 |
| 120 | MAP2K4 | 0.34171130 |
| 121 | IKBKB | 0.33925364 |
| 122 | MOS | 0.32881904 |
| 123 | BRSK1 | 0.31076499 |
| 124 | CAMK1G | 0.30469836 |
| 125 | FLT3 | 0.30389641 |
| 126 | IRAK1 | 0.30174907 |
| 127 | CDK11A | 0.30171889 |
| 128 | BRAF | 0.29769504 |
| 129 | ATR | 0.29165055 |
| 130 | ALK | 0.28876598 |
| 131 | SIK1 | 0.27833711 |
| 132 | PTK6 | 0.26823867 |
| 133 | ABL1 | 0.26115696 |
| 134 | RPS6KA3 | 0.26027532 |
| 135 | CDK14 | 0.25838622 |
| 136 | CAMK2G | 0.25769109 |
| 137 | PRKACA | 0.25491214 |
| 138 | PRKCA | 0.25029317 |
| 139 | PAK3 | 0.24874632 |
| 140 | EPHB1 | 0.23288719 |
| 141 | FGFR4 | 0.23177400 |
| 142 | PRKCH | 0.22833472 |
| 143 | PRKCB | 0.22267876 |
| 144 | RAF1 | 0.21855874 |
| 145 | HCK | 0.21797487 |
| 146 | PRKG1 | 0.21102312 |
| 147 | MAP2K1 | 0.19525423 |
| 148 | DAPK3 | 0.19127958 |
| 149 | DYRK1A | 0.18529132 |
| 150 | PRKD3 | 0.18170117 |
| 151 | PRKCE | 0.17575383 |
| 152 | MAP2K6 | 0.17122280 |
| 153 | GSK3B | 0.16481225 |
| 154 | PDPK1 | 0.15670408 |
| 155 | CSNK1E | 0.15387424 |
| 156 | CDK12 | 0.15187084 |
| 157 | OXSR1 | 0.14422114 |
| 158 | PRKAA1 | 0.14103590 |
| 159 | PRKDC | 0.13796699 |
| 160 | CSNK1G2 | 0.13088599 |
| 161 | PRKACB | 0.11950646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 6.20362175 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 5.00755777 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.29956313 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 3.27114165 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 3.02019494 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.99020880 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.87191458 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82553052 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.75303212 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63121314 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.57169593 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.55930897 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.51926693 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.48119049 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27657231 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.22760925 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.05451250 |
| 18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.98933331 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93347549 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88719066 |
| 21 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.79066780 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.77194112 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.67850500 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.67316046 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66636279 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66463446 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.65034296 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61765829 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.61699414 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61227382 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55505823 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54167560 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53568270 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.52470038 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49158476 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47184512 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44028819 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41617380 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39607518 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.38319895 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37110681 |
| 42 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.33823685 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.33376924 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.32232796 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32107624 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32035212 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29351931 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24587173 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.23517458 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21134777 |
| 51 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.19455014 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18914991 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16643383 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14998768 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14727169 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14125868 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13023630 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09439846 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08931667 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07946483 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07377563 |
| 62 | Glioma_Homo sapiens_hsa05214 | 1.07195756 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04831765 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02170888 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01957542 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.00266647 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99962534 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96341799 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93873286 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93193117 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92915083 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92520320 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.92453850 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87889090 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87248288 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84970192 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83628607 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82774880 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79615537 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79502147 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.78784124 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78618975 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75686635 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74352590 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74254610 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.73530516 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71815626 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.71127053 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69149853 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67909859 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.64866624 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64214323 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64139481 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.63410968 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62887565 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62885421 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62618811 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62314510 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62278563 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61786711 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60801004 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59890340 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59619887 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58606458 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58486411 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.58054339 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.57878327 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56140851 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54379544 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53181763 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52098507 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52080425 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51992600 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51234004 |
| 115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50993294 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49974764 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49712584 |
| 118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49327215 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47278240 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47267134 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46804581 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46305221 |
| 123 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46004582 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46001737 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.45009790 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43718595 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43354884 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.40614374 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40569406 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40205993 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39282668 |
| 132 | Purine metabolism_Homo sapiens_hsa00230 | 0.38407414 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.37481100 |
| 134 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36928472 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.36239705 |
| 136 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35731704 |
| 137 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35653358 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35152684 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.34168949 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33702251 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32057054 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.31754243 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28801704 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27087660 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26628459 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26181428 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25817707 |
| 148 | Lysine degradation_Homo sapiens_hsa00310 | 0.23483147 |
| 149 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22888735 |
| 150 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22292585 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21113274 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20898433 |
| 153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18480725 |
| 154 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16884542 |
| 155 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16117614 |
| 156 | Alcoholism_Homo sapiens_hsa05034 | 0.16110015 |
| 157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14930177 |
| 158 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14916202 |

